Concurrent Influenza and Shigellosis Outbreaks, Papua New Guinea, 2009
نویسندگان
چکیده
1. Nishimoto N, Yoshizaki K, Miyasaka N, Yamamoto K, Kawai S, Takeuchi T, et al. Treatment of rheumatoid arthritis with humanized anti-interleukin-6 receptor antibody: a multicenter, double-blind, placebo-controlled trial. Arthritis Rheum. 2004;50:1761–9. DOI: 10.1002/art.20303 2. European Medicines Agency. Actemra (tocilizumab): summary of product characteristics, 2009 [cited 2009 Mar 23]. http:// www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/000955/WC500054890.pdf 3. Kim SY, Solomon DH. Tumor necrosis factor blockade and the risk of viral infection. Nat Rev Rheumatol. 2010;6:165–74. DOI: 10.1038/nrrheum.2009.279 4. Ramshaw IA, Ramsay AJ, Karupiah G, Rolph MS, Mahalingam S, Ruby JC. Cytokines and immunity to viral infections. Immunol Rev. 1997;159:119–35. DOI: 10.1111/j.1600-065X.1997.tb01011.x 5. Dixon WG, Symmons DP, Lunt M, Watson KD, Hyrich KL, Silman AJ. Serious infection following anti-tumor necrosis factor alpha therapy in patients with rheumatoid arthritis: lessons from interpreting data from observational studies. Arthritis Rheum. 2007;56:2896–904. DOI: 10.1002/art.22808 6. Genovese MC, McKay JD, Nasonov EL, Mysler EF, da Silva NA, Alecock E, et al. Interleukin-6 receptor inhibition with tocilizumab reduces disease activity in rheumatoid arthritis with inadequate response to disease-modifying antirheumatic drugs: the tocilizumab in combination with traditional disease-modifying antirheumatic drug therapy study. Arthritis Rheum. 2008;58:2968–80. DOI: 10.1002/ art.23940 7. Smolen JS, Beaulieu A, Rubbert-Roth A, Ramos-Remus C, Rovensky J, Alecock E, et al. Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial. Lancet. 2008;371:987–97. DOI: 10.1016/S0140-6736(08)60453-5 8. Nishimoto N, Miyasaka N, Yamamoto K, Kawai S, Takeuchi T, Azuma J. Long-term safety and effi cacy of tocilizumab, an anti-IL-6 receptor monoclonal antibody, in monotherapy, in patients with rheumatoid arthritis (the STREAM study): evidence of safety and effi cacy in a 5-year extension study. Ann Rheum Dis. 2009;68:1580–4. DOI: 10.1136/ard.2008.092866 9. Yokota S, Imagawa T, Mori M, Miyamae T, Aihara Y, Takei S, et al. Effi cacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebocontrolled, withdrawal phase III trial. Lancet. 2008;371:998–1006. DOI: 10.1016/ S0140-6736(08)60454-7 10. Nishimoto N, Ito K, Takagi N. Safety and effi cacy profi les of tocilizumab monotherapy in Japanese patients with rheumatoid arthritis: meta-analysis of six initial trials and fi ve long-term extensions. Mod Rheumatol. 2010;20:222–32. DOI: 10.1007/ s10165-010-0279-5
منابع مشابه
Methicillin-Resistant Staphylococcus Aureus in Melanesian Children with Haematogenous Osteomyelitis from the Central Highlands of Papua New Guinea
Background: Methicillin-Resistant Staphylococcus aureus (MRSA) has been an important cause of bone infection since the 1940s. Current guidelines recommend targeted antibiotic use for osteomyelitis treatment informed by microbial sensitivity patterns. However, in settings without microbiology facilities, empirical antibiotic use is common. Unrecognized antibiotic resistance potentiates persisten...
متن کاملGlobal Health Diplomacy, National Integration, and Regional Development through the Monitoring and Evaluation of HIV/AIDS Programs in Papua New Guinea, Vanuatu, and Samoa
The South Pacific countries of Vanuatu, Samoa, and Papua New Guinea have ascended rapidly up the development spectrum in recent years, refining an independent and post-colonial economic and political identity that enhances their recognition on the world stage. All three countries have overcome economic, political and public health challenges in order to stake their claim to sovereignty. In this...
متن کاملA large outbreak of shigellosis commencing in an internally displaced population, Papua New Guinea, 2013.
OBJECTIVE The objective of this study was to investigate a large outbreak of shigellosis in Papua New Guinea that began in a camp for internally displaced persons before spreading throughout the general community. METHODS Outbreak mitigation strategies were implemented in the affected area to curtail the spread of the disease. Data were collected from the surveillance system and analysed by t...
متن کاملA Partnership Model for Improving Service Delivery in Remote Papua New Guinea: A Mixed Methods Evaluation
Background The Community Mine Continuation Agreement Middle (CMCA) and South Fly Health Program (the Health Program) is a partnership for improving health service delivery in remote Papua New Guinea (PNG). The Health Program is delivered by a private contractor working in partnership with existing health service providers to improve service delivery using existing government systems, where poss...
متن کاملInfluenza in the Pacific.
Influenza A and B viruses cause significant human disease worldwide through regular outbreaks and epidemics of seasonal influenza, and occasional pandemics when a novel influenza A virus emerges. Whereas Australia and New Zealand have well-established systems for community and laboratory-based surveillance of influenza, most other countries of the Pacific are only beginning to develop such syst...
متن کاملImproved laboratory capacity is required to respond better to future cholera outbreaks in Papua New Guinea.
WPSAR Vol 3, No 2, 2012 | doi: 10.5365/wpsar.2011.2.4.016 www.wpro.who.int/wpsar 1 a Papua New Guinea Institute of Medical Research, Goroka, Papua New Guinea. b World Health Organization, Port Moresby, Papua New Guinea. c School of Public Health and Community Medicine, University of New South Wales, Sydney, Australia. d School of Medicine and Pharmacology, University of Western Australia, Perth...
متن کامل